Large-scale testing (Phase 3)Not Yet RecruitingNCT07694427
What this trial is testing
Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]
Who this might be right for
Ovarian Neoplasms
GlaxoSmithKline 720